BioAtla, Inc.
BCAB
$0.356
-$0.0002-0.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.00M | 11.00M | 11.00M | 11.00M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.00M | 11.00M | 11.00M | 11.00M | -- |
| Cost of Revenue | 40.97M | 41.56M | 48.06M | 59.09M | 71.09M |
| Gross Profit | -29.97M | -30.56M | -37.06M | -48.09M | -71.09M |
| SG&A Expenses | 20.69M | 21.50M | 21.85M | 23.12M | 23.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 74.78M | 78.10M | 84.94M | 97.24M | 109.99M |
| Operating Income | -63.78M | -67.10M | -73.94M | -86.24M | -109.99M |
| Income Before Tax | -59.52M | -61.88M | -69.78M | -81.82M | -104.56M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.52 | -61.88 | -69.78 | -81.82 | -104.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.52M | -61.88M | -69.78M | -81.82M | -104.56M |
| EBIT | -63.78M | -67.10M | -73.94M | -86.24M | -109.99M |
| EBITDA | -63.02M | -66.23M | -73.02M | -85.17M | -108.88M |
| EPS Basic | -1.10 | -1.22 | -1.44 | -1.70 | -2.18 |
| Normalized Basic EPS | -0.69 | -0.76 | -0.90 | -1.06 | -1.36 |
| EPS Diluted | -1.10 | -1.22 | -1.44 | -1.70 | -2.18 |
| Normalized Diluted EPS | -0.69 | -0.76 | -0.90 | -1.06 | -1.36 |
| Average Basic Shares Outstanding | 214.74M | 204.45M | 194.29M | 192.63M | 192.13M |
| Average Diluted Shares Outstanding | 214.74M | 204.45M | 194.29M | 192.63M | 192.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |